BMS-181-165

N/A

Report date: 2023/10/16 09:01:19
NME

Base Information

Drug NameBMS-181-165
Drug Alias NameBMS-181-165BMS-181165BMS-181,165
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionVirus DNA polymerase inhibitors
TargetsVirus DNA polymerase
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A